Ultra-rapid opioid detoxification: Current status and controversies

Journal of Postgraduate Medicine

Volumn 50, Issue 3, 2004, Pages 227-232

  Singh, J ^a   Basu, Debasish ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Anaesthesia assisted detoxification; Detoxification; Opioid abuse; Ultra rapid detoxification

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ANALGESIC AGENT; ANESTHETIC AGENT; ANTIEMETIC AGENT; BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; CLONIDINE; DEXMEDETOMIDINE; DROPERIDOL; HYPNOTIC AGENT; LEVACETYLMETHADOL; LONG ACTING DRUG; METHADONE; METHOHEXITAL; MIDAZOLAM; MIVACURIUM; MORPHINE; MU OPIATE RECEPTOR ANTAGONIST; MUSCLE RELAXANT AGENT; NALMEFENE; NALOXONE; NALTREXONE; ONDANSETRON; OPIATE; OPIATE ANTAGONIST; PROPOFOL; RINGER LACTATE SOLUTION; SUXAMETHONIUM; THIOPENTAL; UNINDEXED DRUG;

ANESTHESIA INDUCTION; ANESTHESIOLOGICAL TECHNIQUES; CLINICAL STUDY; CLINICAL TRIAL; DRUG DEPENDENCE; DRUG DETOXIFICATION; DRUG MECHANISM; DRUG SELECTIVITY; EVIDENCE BASED MEDICINE; GENERAL ANESTHESIA; HEART ARREST; HOSPITAL DISCHARGE; HUMAN; INTERMETHOD COMPARISON; LUNG EDEMA; MAINTENANCE THERAPY; MEDICAL ETHICS; MEDICAL PRACTICE; PATIENT MONITORING; PREMEDICATION; PSYCHOTHERAPY; PUBLIC HEALTH; RELAPSE; REVIEW; SAFETY; SEDATION; STANDARD; THEORY; TIME; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

ANESTHESIA, GENERAL; HUMANS; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 7444270984     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Jaffe JH, Jaffe AB. Opioid related disorders. In: Sadock BJ, Sadock VA, eds. Comprehensive Textbook of Psychiatry, 7th edn. New York, Lippincott Williams and Wilkins; 2000. p1038-63.
2. Charney DS, Heninger GR, Kleber HD. The combined use of clonidine and naltrexone as a rapid, safe and effective treatment of abrupt withdrawal from methadone. Am J Psychiatry 1986;143:831-7.
3. Gevirtz C. Anesthesia assisted opiate detoxification. Int Anesthesiol Clin 2003;41:79-93.
4. Loimer N, Linzmayer L, Grunberger J. Comparison between observer assessment and self-rating of withdrawal distress during opiate detoxification. Drug Alcohol Depend 1991;28:265-8.
5. Dole VP, Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction. JAMA 1965;193:646-50.
6. Kurland AA, McCabe L. Rapid detoxification of the narcotic addict with naloxone hydrochloride: A preliminary report. J Clin Pharmacol 1976;16;66-74.
7. Tretter F, Burkhardt D, Bussello-Spieth B, Reiss J, Walcher S, Buchele W. Clinical experience with antagonist induced opiate withdrawal under anesthesia. Addiction 1998;93:269-75.
8. Blachley P, Casey D, Marcel L, Demey DD. Rapid detoxification from heroin and methadone using naltrexone. A model for the treatment of the opiate abstinence syndrome. In: Senay E, Shorty V, Alkene H, ads. Developments in the field of drug abuse. Cambridge, MA: Schenkman Publishing Co;1975. p 327-36.
9. Loimer N, Schmidt R, Presslich O, Lenz K. Continuous naloxone administration suppresses withdrawal symptoms in human opiate addicts during detoxification treatment. J Psychiatry Res 1989;23:81-6.
10. Riordan CE, Kleber HD. Rapid opiate detoxification with clonidine and naloxone. Lancet 1980;1:1079-80.
11. Vining E, Kosten TR, Kleber HD. Clinical utility of rapid clonidine-naltrexone detoxification for opioid abusers. Br J Addict 1988;83:567-75.
12. Javier Alvarez F, Carmen del Rio M. Ultra-rapid opiate detoxification: a look at what is happening in Spain. Addiction 1999;94:1239-40.
13. Rasmussen K, Beidner Johnson DB, Krystal JH, Aghajanian GK, Nastler EJ. Opiate withdrawal and the rat locus coeruleus: Behavioral, electrophysiological and bio-chemical correlates. J Neurosci 1990;10:2308-17.
14. Spanagel R. Is there a pharmacological basis for therapy with rapid opioid detoxification? Lancet 1999;354:2017-8.
15. Streel E, Verbanck P. Ultrarapid Opioid Detoxification: From clinical application to basic science. Addict Biol 2003;8:141-6.
16. Spanagel R, Kirschke C, Tretter F, Holsboer F. Forced opioid withdrawal under anesthesia augments and prolongs the occurrence of withdrawal signs in rats. Drug Alcohol Depend 1998;52:251-6.
17. Loimer N, Schmidt R, Presslich O, Lenz K. Naloxone treatment for opiate withdrawal syndrome. Br J Psychiatry 1988;153:851-2.
18. Stephenson J. Experts debate the merit of 1-day opiate detoxification under anesthesia. JAMA 1997;277:363-4.
19. Resnick RB, Kestenbaum RS, Washton A, Poole D. Naloxone precipitated withdrawal: A method for rapid induction onto naltrexone. Clin Pharmacol Ther 1977;21:409-13.
20. Johnson TS, Carr M. Naltrexone mediated opiate detoxification: a matter of terminology! (Editorial). Addict Biol 2003;8:267-9.
21. Bell J, Kimber J, Lintzeris N. Guidelines for rapid detoxification from opioids. NSW Health, circular no. 2001/17, file no. 00/1287, issued on 23 February 2001 http://www.health.nsw.gov.au/public-health/dpb/publications/pdf/ rapiddetoxification_cir2001-17.pdf
22. Legarda JJ, Gossop M. A 24-hour inpatient detoxification programme for heroin addicts: a preliminary investigation. Drug Alcohol Depend 1994;35:91-3.
23. Lorenzi P, Marsili M, Boncinelli S, Fabbri LP, Fontanari P, Zorn AM et al. Searching for a general anesthetic protocol for rapid detoxification from opioids Eur J Anaesthesiol 1999;16:719-27.
24. Stine SM, Kosten TR. Use of drug combinations in the treatment of opioid withdrawal. J Clin Psychopharmacol 1992;12:203-9.
25. Hensel M, Kox WJ. Safety, efficacy and long term results of a modified version of rapid opiate detoxification under general anesthesia: A prospective study in methadone, heroin, codeine and morphine addicts. Acta Anesth Scand 2000;44:326-33.
26. Streel E, Dan B, Bredas P, Clement B, Pelc I, Verbanck P. Interference with withdrawal signs of naloxone induced opiate withdrawal under anaesthesia is anaesthetic specific in opiate dependent rats. Life Sci 2001;70:517-22.
27. Cucchia AT, Monnat M, Spagnoli J, Ferrero F, Bertschy C. Ultra-rapid opiate detoxification using deep sedation with oral midazolam: short and long term results. Drug Alcohol Depend 1998;52:243-50.
28. Demaria PA Jr, Rogers C, Braccia G. Propofol for sedation during rapid opiate detoxification. Am J Psychiatry 1997;154:290-1.
29. Kienbaum P, Scherbaum N, Thurauf N, Michel M Gastpar M, Peters J. Acute detoxification of opioid addicted patients with naloxone during propofol or methohexital anesthesia: A comparison of withdrawal symptoms, neuroendocrine, metabolic and cardiovascular patterns. Crit Care Med 2000;28:969-76.
30. Scherbaum N, Klein S, Kaube H, Kienbaum P, Peters J, Gastpar M. Alternative strategies of opiate detoxification: evaluation of the so-called ultra-rapid detoxification. Pharmacopsychiatry 1998;31:205-9.
31. Gold CG, Cullen DJ, Gonzales S, Houtmeyers D, Dwyer MJ. Rapid opioid detoxification during general anesthesia: a review of 20 patients. Anesthesiology 1999;91:1639-47.
32. Bell J, Young M, Masterman S, Morris A, Mattick RP, Bammer G. A pilot study of naltrexone accelerated detoxification in opioid dependence. Med J Aust 1999;171:26-30.
33. London M, Paul E, Gkolia I. Ultra-rapid detoxification in hospital. Psy Bull 2000;23:544-6.
34. Roozen RG, de Kan R, van den Brink W, Kerkof AF, Geerlings PJ. Dangers involved in rapid opioid detoxification while using opioid antagonists: dehydration and renal failure. Addiction 2002;97:1071-3.
35. Gooberman LL, Brewer C. Patent 5789411, US Patent office, Aug. 4. 1998.
36. Simon DL. The rationale for naltrexone therapy as an alternative to methadone treatment for opiate addiction. Conn Med 1996;60:683-5.
37. Kienbaum P, Thurauf N, Michel M, Scherbaum N, Gastpar M, Peters J. Profound increase in epinephrine concentration in plasma and cardiovascular stimulation after mu-receptor blockade in opioid addicted patients during barbiturate induced anesthesia for acute detoxification. Anesthesiology 1998;88:1154-61.
38. Allhoff T, Renzing Kohler K, Kienbaum P, Sack S, Scherbaum N. Electrocardiographic abnormalities during recovery from ultra short opiate detoxification. Addict Biol 1999;4:337-44.
39. Albanese AP, Gevirtz C, Oppenheim B, Field JM, Abels I, Eustace JC. Outcome and six month follow up of patients after Ultra-rapid Opiate Detoxification. J Addict Dis 2000;19:11-28.
40. Pfab R, Hirti C, Zilker T. Opioid detoxification under anesthesia: no apparent benefit but suppression of thyroid hormones and risk of pulmonary and renal failure. J Pharmacol Clin Toxicol 1999;37:43-50.
41. Kaye AD, Gevirtz C, Bosscher HA, Duke JB, Frost EA, Richards TA, et al. Ultrarapid opiate detoxification: a review. Can J Anaesth 2003;50:663-71.
42. Dyer C. Addict died after rapid opiate detoxification. BMJ 1998;316:170.
43. Gowing L, Ali R, White J. Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal. The Cochrane Library, Oxford: Update Software 2002;2.
44. O'Connor PG, Waugh ME, Carroll KM, Rounsaville BJ, Diagkogiannis IA, Schottenfeld RS. Primary care-based ambulatory opioid detoxification: the results of a clinical trial. J Gen Intern Med 1995;10:255-60.
45. Taff RH. Pulmonary edema following naloxone administration in a patient without heart disease. Anesthesiology 1983:59:576-7.
46. Mattick RP, Hall W. Are detoxification programmes effective? Lancet 1996;347:97-100.
47. Gold ML, Sorenson JL, Mc Canlies N, Trier M, Dlugosch G. Tapering from methadone treatment: Attitudes of client & staff. J Subst Abuse Treat 1988;5:37-44.
48. O'Connor PG, Kosten TR. Rapid and ultrarapid opioid detoxification techniques. JAMA 1998;279:229-34.
49. Seoane A, Carrasco G, Cabre L, Puigross A, Hernandez E, Alvarez M. Efficacy and safety of two new methods of rapid intravenous detoxification in heroin addicts previously treated without success. Br J Psychiatry 1997;171:340-5.
50. Laheji RJ, Krabbe PF, de Jong CA. Rapid heroin detoxification under general anesthesia. JAMA 2000;283:1143.
51. Lawental E. Ultra-rapid opiate detoxification as compared to 30-day inpatient detoxification programme - a retrospective study. J Subst Abuse 2000;11:173-81.
52. Krabbe PF, Koning JP, Heinen N, Laheji RJ, Van Cauter VM, De Jong CA. Rapid detoxification from opioid dependence under general anesthesia versus standard methadone tapering: abstinence rates and withdrawal distress experiences. Addict Biol 2003;8:351-8.
53. Bochud Tornay C, Favrest B, Monnat M, Daeppen JB, Schnyder C, Bertschy G, et al. Ultra-rapid opiate detoxification using deep sedation and prior oral buprenorphine preparation. Drug Alcohol Depend 2003;69:283-8.
54. Brewer C. Attitudes to abortion, methadone maintenance and human opiate withdrawal among health professionals: A depressing analogy. Addict Res 1995;3:1-5.
55. Brewer C, Williams J, Carreno Rendueles E, Garcia JB. Unethical promotion of rapid opiate detoxification under anesthesia (RODA). Lancet 1998;351:218.
56. Jhirwal OP, Basu D. Ultra-rapid opioid detoxification procedures in India: how far are they ethical? Indian J Med Sci 2004;58:132-3.
57. Public policy statement on Opioid Antagonist Detoxification Under Sedation or Anesthesia (OADUSA). American Society of Addiction Medicine (ASAM) J Addict Dis 2000;19:109-12.